FDA Dumps Rigid Methods Rule to Streamline Enforcement Testing
Published Date: 2/19/2026
Rule
Summary
The FDA is officially scrapping a rule that told them which testing methods to use when no specific method was required by law. This change affects anyone involved in FDA enforcement programs but won’t cost extra or cause delays. The new rule kicks in on March 23, 2026, making things simpler and more flexible for everyone.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
Validation and accreditation remain required
FDA states the revocation does not permit use of unvalidated methods and that methods used by FDA will continue to undergo qualification, validation, and fitness-for-use, including under ISO/IEC 17025 accreditation frameworks and the Laboratory Accreditation for Analyses of Foods (LAAF) program where applicable.
FDA drops AOAC default rule
The FDA removed 21 CFR 2.19, which said the Agency would default to AOAC (13th Ed., 1980) methods in enforcement programs when no method is specified by law. The revocation becomes effective March 23, 2026 and means FDA is no longer required to use that single compendium as its default.
No monetized costs or savings
FDA estimates the final rule will produce $0 in annualized monetized costs and $0 in monetized benefits (at both 3% and 7% discount rates, annualized over 10 years). The Agency also certified the rule will not have a significant economic impact on a substantial number of small entities.
FDA will list preferred methods in guidance
Instead of relying on a single incorporated compendium, FDA will identify preferred and validated analytical methods in documents that can be updated more frequently (for example, Agency methods compendia, compliance program guidance, and other resources). This is intended to allow more flexibility and quicker updates as science advances.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16944, Gardenia Blue Interest Group; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Gardenia Blue Interest Group (GBIG or petitioner), c/o Exponent, Inc., proposing that we amend our color additive regulations to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice. The petition also proposes to lower the specification for arsenic in gardenia (genipin) blue.
Previous / Next Documents
Previous: 2026-03284, Amendment of Class D, Class E2, Class E4 and Class E5 Airspace Over Patuxent River, MD
The FAA is updating the airspace rules around Patuxent River Naval Air Station in Maryland to better cover all flight operations and remove outdated navigation references. These changes affect pilots flying under instrument flight rules and take effect on May 14, 2026. No new fees or costs are involved—just clearer, safer skies!
Next: 2026-03286, Revocation of Regulations Regarding the Mutual Recognition of Pharmaceutical Good Manufacturing Practice Reports, Medical Device Quality System Audit Reports, and Certain Medical Device Product Evaluation Reports: United States and the European Community
Starting March 23, 2026, the FDA is canceling old rules that let the U.S. and European Union share certain drug and medical device inspection reports. These rules are outdated because a newer agreement from 2017 already covers this sharing. Companies making medicines and medical devices in both places should note this change, but it won’t add extra costs or delays.